Search
xanomeline
Indications:
- used in combination with tropsium for treatment of schizophrenia
Adverse effects:
- cholinergic adverse effects
Mechanism of action:
- muscarinic receptor agonist
- no dopamine receptor antagonist activity
General
muscarinic receptor agonist
References
- Shekhar A et al.
Selective muscarinic receptor agonist xanomeline as a novel
treatment approach for schizophrenia.
Am J Psychiatry 2008 Aug; 165:1033.
PMID: 18593778
- Brannan SK, Sawchak S, Miller AC et al
Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist
for Schizophrenia.
N Engl J Med 2021; 384:717-726 Feb 25
PMID: 33626254
https://www.nejm.org/doi/full/10.1056/NEJMoa2017015B
Component-of
tropsium chloride/xanomeline (Cobenfy, KarXT)